
Trump says he's ‘highly unlikely' to fire Fed's Powell after floating that idea in private
Trump confirmed that in a White House meeting Tuesday night with about a dozen House Republicans he had discussed the 'concept' of dismissing Powell, long a target because of his refusal to lower interest rates as Trump wants.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Toronto Star
38 minutes ago
- Toronto Star
Florida Rep. Joe Casello dies while in office
BOYNTON BEACH, Fla. (AP) — Florida Democratic lawmaker Joe Casello has died while in office following a heart attack, according to state House officials. He was 73. Casello, who was first elected to the Florida House in 2018 from a district in Boynton Beach, was surrounded by his girlfriend and family when he died Friday, the Florida House Democratic Caucus said in a social media post.


Winnipeg Free Press
38 minutes ago
- Winnipeg Free Press
Florida Rep. Joe Casello dies while in office
BOYNTON BEACH, Fla. (AP) — Florida Democratic lawmaker Joe Casello has died while in office following a heart attack, according to state House officials. He was 73. Casello, who was first elected to the Florida House in 2018 from a district in Boynton Beach, was surrounded by his girlfriend and family when he died Friday, the Florida House Democratic Caucus said in a social media post. 'The family extends their heartfelt gratitude to all who have offered their love and support during this difficult time,' the caucus said in a statement. Casello was a firefighter in Worcester, Massachusetts, for three decades before entering politics in Florida. He served as a Boynton Beach city commissioner before becoming a state lawmaker. He had announced plans to run for a seat on the Palm Beach County Commission in 2026. Under Florida law, Gov. Ron DeSantis is required to call a special election or special primary election when a vacancy occurs for a legislative seat because of a death.


Toronto Star
an hour ago
- Toronto Star
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
WASHINGTON (AP) — Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a third patient receiving one of its treatments for muscular dystrophy. The highly unusual move is a latest in a string of events that have hammered the company's stock for weeks and recently forced it to lay off 500 employees. The company's decision not to comply with the FDA also places future availability of its leading therapy, called Elevidys, in doubt.